|
Horse number
|
Breed
|
Age (y)
|
Gender
|
Purpose used for
|
Reported duration of SDFT tendinopathy until initial exam (w)
|
Reported initiating event
|
Limb affected
|
Maximal injury zone (MIZ)
|
Lesion type
|
|---|
|
PRP-group
|
|
1
|
Hannoverian
|
4
|
G
|
Dressage
|
2
|
Unknown
|
LF
|
2a, lat
|
Marginal
|
|
2
|
Hannoverian
|
8
|
M
|
Dressage
|
1
|
Training
|
LF
|
3a, palm
|
Marginal
|
|
3
|
Haflinger
|
21
|
G
|
Trained horse
|
2
|
Pasture turnout
|
LF
|
2b
|
Diffuse
|
|
4
|
Trakehner
|
5
|
S
|
Dressage
|
4
|
Pasture turnout
|
RF
|
3b, med
|
Marginal
|
|
5
|
Oldenburger
|
16
|
G
|
Police horse
|
2
|
Ride
|
RF
|
2b
|
Diffuse
|
|
6
|
Rhenish Warmblood
|
13
|
M
|
Dressage
|
2
|
Unknown
|
RF
|
3a
|
Core
|
|
7
|
Hannoverian
|
6
|
M
|
Dressage
|
2
|
Running free
|
LF
|
2b, palm
|
Marginal
|
|
8
|
New Forest Pony
|
13
|
G
|
Pleasure
|
3
|
Pasture turnout
|
LF
|
2b
|
Diffuse
|
|
9
|
Hannoverian
|
11
|
G
|
Eventing
|
8
|
Training
|
RF
|
3a
|
Core
|
|
10
|
Pinto
|
20
|
G
|
Pleasure
|
7
|
Unknown
|
LF
|
2b, lat
|
Marginal
|
| | | ∅ 11.7 | | | | | | | |
|
Control group
|
|
1
|
Oldenburger
|
9
|
M
|
Jumping
|
4
|
Jumping
|
LF
|
3a, lat
|
Marginal
|
|
2
|
Hannoverian
|
5
|
G
|
Dressage
|
6
|
Unknown
|
LF
|
3a, med
|
Marginal
|
|
3
|
Andalusian
|
18
|
M
|
Pleasure
|
3
|
Pasture turnout
|
LF
|
2b
|
Diffuse
|
|
4
|
Hannoverian
|
15
|
M
|
Dressage, jumping
|
2
|
Training
|
LF
|
2b, med
|
Marginal
|
|
5
|
German Riding Pony
|
9
|
M
|
Jumping
|
1
|
Jumping
|
LF
|
3a, lat
|
Marginal
|
|
6
|
Hannoverian
|
12
|
G
|
Police horse
|
2
|
Running free
|
RF
|
1b, lat
|
Marginal
|
|
7
|
Hannoverian
|
20
|
M
|
Pleasure
|
2
|
Unknown
|
RF
|
2a
|
diffuse
|
|
8
|
Rhenish Warmblood
|
7
|
G
|
Eventing
|
2
|
Training
|
LF
|
3a
|
Core
|
|
9
|
Hannoverian
|
10
|
G
|
Eventing
|
6
|
Jumping
|
LF
|
2b, lat
|
Marginal
|
|
10
|
Hannoverian
|
6
|
G
|
Pleasure
|
4
|
Unknown
|
RF
|
3a
|
Diffuse
|
| | | ∅ 11.1 | | | | | | | |
-
SDFT superficial digital fexor tendon, w week(s), y years, S stallion, M mare, G gelding, LF left front, RF right front, PRP-group SDFT treated with intralesional injection of platelet-rich plasma, Control group SDFT treated with intralesional saline injection, lat lateral, med medial, palm palmar, ∅ mean
